Quest Pharmatech News Today

Focal Therapy for Prostate Cancer Therapeutics Market by Type, by End User (Hospitals & Specialty Clinics, Cancer Treatment Centers), and by Region – Global Share and Forecast to 2033

Quest PharmaTech Inc. (CVE:QPT – Get Free Report)’s share price reached a new 52-week low during trading on Wednesday . The company traded as low as C$0.02 and last traded at C$0.02, with a volume of 7000 shares. The stock had previously closed at C$0.03. Quest PharmaTech Price Performance The company has a quick ratio […]

Quest PharmaTech Inc. announced that it has received information that the Phase III clinical trial of oregovomab for the treatment of Ovarian Cancer, sponsored by CanariaBio Inc. , has received...

Quest PharmaTech Inc. (CVE:QPT – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.05 and last traded at C$0.05, with a volume of 81844 shares trading hands. The stock had previously closed at C$0.05. Quest PharmaTech Price Performance The company has a debt-to-equity […]

Quest PharmaTech Inc. (CVE:QPT – Get Free Report) shares hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.05 and last traded at C$0.05, with a volume of 77000 shares traded. The stock had previously closed at C$0.06. Quest PharmaTech Price Performance The firm has a 50 day […]

/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Photodynamic Therapy Market Overview, Component, Industry...

A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER June 30, 2023 Dear shareholders, ...

Share this article TSX Venture: QPT                                                                      EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc. ("OQP") lead clinical candidate oregovomab, will be making two presentations as part of the American Society of Clinical Oncology (ASCO) ...

  Latest research study from JCMR with title Global Photodynamic Therapy Market by Manufacturers, Regions, Type and Application, Forecast to 2022-2029. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data. The study is segmented by products type & Applications. The research study provides estimates for and Photodynamic Therapy...

Share: TSX Venture: QPT EDMONTON, AB, Jan. 5, 2021 /CNW/ - Quest PharmaTech Inc. (TSXV:QPT) ("Quest") provides update to its June 4, 2020 news release to announce that one of its equity investee companies, OncoQuest Inc. ("OncoQuest"), completed the transfer of the immunotherapy technology assets to OncoQuest Pharmaceuticals, Inc, a KOSDAQ traded company ("OQP", 078590.KQ) on November 7, 2020. However, due to COVID-19 related Korean courts restrictions, final payment of 65,229,709 shares of OQP...